Yes! You read that right!

Simple preventative actions could decrease the rate of #posteriorfossasyndrome by up to 75%. A significant challenge is the lack of awareness. As #neuroradiologists , we can play a crucial role in reducing these occurrences. I believe organizations like…

Symbolizing hope through change, live butterflies were released on campus yesterday to mark our commitment to advancing cures for pediatric #EpENDymomas . With the guidance of CERN Foundation, the event also featured talks from Stephen C. Mack, Dr. Bertrand & inspiring patient families

Up to 40% of patients with medulloblastoma receive a diagnosis of #posteriorfossasyndrome , yet simple & preventative measures could reduce the incidence by 75%. Today, I presented findings from the St. Jude Research clinical trial #SJMB12 on the experience with PFS. posteriorfossasociety

The Posterior Fossa Society meeting has just started! Don’t miss my presentation on “The Posterior Fossa Experience at St. Jude Research and the Value of a Clinical Trial” tomorrow at 8:15am.

Today at #AACR24 , St. Jude
Molecular Neuro-Oncology chair
Paul Northcott, PhD, hosts a session highlighting recent advances in clinically aggressive childhood cancers in Advances in Pediatric Cancer: Mechanisms, Vulnerabilities, and Translation.

Don't miss the chance to register for the posteriorfossasociety Society meeting at St. Jude Research on April 12-14. The meeting will serve as a catalyst for collaboration & innovation, laying the foundation for further research & improvements in patient care. tinyurl.com/4m7uhkp2

Proud to be introducing my mentee Giles Robinson at his faculty promotion seminar today. In his work, Giles has greatly impacted the landscape of pediatric #braintumor research & care. Today marks a significant step in his career path.

The 2024 posteriorfossasociety global meeting provides a necessary step towards greater alignment on the characterization of #posteriorfossasyndrome amongst #braintumor providers, which would help further #PFS research and clinical care. Register today: stjude.org/pbii-symposium

Tomorrow, at 11am, I will be presenting my faculty promotion seminar titled 'Revolutionizing Pediatric CNS Tumor Treatment Through an Improved Understanding of Disease' at St. Jude Research. Thrilled to have Amar Gajjar introduce me to the stage. #NeuroOnc

The 2024 Global posteriorfossasociety Society meeting will be hosted on April 12-14 at St. Jude Research. Join us as we cover various topics to improve outcomes for #posteriorfossasyndrome patients including scoring, imaging, surgery & rehabilitation. Register: tinyurl.com/37r2mkmf

St. Jude, recently ranked among the top workplaces for women, provides ample resources for female scientists & clinicians to conduct innovative research. On #InternationalWomensDay , our team celebrates the female neuro-oncologists working to advance cures. tinyurl.com/mr3wv4eh

#SJiMB21 is set to launch in 15 sites across the U.S, New Zealand & Australia. In this article, Children's Minnesota discusses how its collaboration with St. Jude on this trial can help accelerate progress on research and care for infants with #braintumors . tinyurl.com/3md3jp46

Our front-line infant medulloblastoma trial is now open to enrollment in Children's Minnesota childrensmn.org/2024/02/16/two…

Congratulations Sara Federico on being named the director of the Solid Tumor Division at the St. Jude Children’s Research Hospital - Giles Robinson
St. Jude Research

#Cancer #ChildhoodCancer #OncoDaily #Oncology #PediatricOncology #SolidTumors

oncodaily.com/35794.html

On International Childhood Cancer Day, we highlight our program's commitment to improving outcomes for children with #braintumors by collaborating with researchers across disciplines to translate lab findings into opportunities for treatment. tinyurl.com/mr2pddar #ICCD2024 🎗️

#PosteriorFossaSyndrome is a disorder of speech, movement & affect that can occur in children after surgery involving the cerebellum. In a Brain paper, we use fMRI of key brain areas involved in speech to help identify the underlying mechanisms. tinyurl.com/4y79sbxn

#SJ901 , a @stjuderesearch study using a Mirdametnib to treat children & AYAs with low-grade glioma, is enrolling patients in one of 3 treatment cohorts based   on tumor status & history of MEK inhibitor exposure. Learn more: stjude.org/sj901 #PLGG Giles Robinson

mvp moment: st. jude patient rinoa's no more chemo party

for us it's one of our biggest celebrations 🥳

#Ependymoma research has vastly evolved over the last years with ten different molecular subgroups now described, but progress is still needed to develop new therapeutic strategies and targets. Read the review: tinyurl.com/3xtuezja Paul Klimo Jr. MD MPH

As always, blown away by the #medulloblatoma talk by paul northcott🇨🇦 of St. Jude Research in the #StJudeGrowingScience faculty retreat!

Get ready folks, Gr3/4 #medulloblastoma now has 8 subtypes!!!!